Inovio Pharma’s net loss was $2.84m or $0.02 loss per diluted share, compared to $7.61m, or $0.07 per diluted share, for the same period in 2010.
The company’s loss from operations for the second quarter of 2011 was $5.14m, compared to $4.98m for the same period in 2010.
For the six months ended 30 June 2011, the company reported a total revenue of $5.53m, compared to $2.51m for the same period in 2010.
The company has reported net loss of $5.26m or 0.04 loss per diluted share for the six months ended 30 June 2011, as compared to $9.91m or $0.10 loss per diluted share for the same period in 2010.
Inovio Pharma’s loss from operations was $9.52m for the six months of 2011, compared to $9.38m for the same period in 2010.